These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 1258215

  • 1. [Use of immunotherapy in the treatment of malignant melanoma of the skin].
    Kristensen E.
    Ugeskr Laeger; 1976 Feb 16; 138(8):468-73. PubMed ID: 1258215
    [No Abstract] [Full Text] [Related]

  • 2. [Immunotherapy of malignant melanomas].
    Macher E.
    Haematol Blood Transfus; 1978 Feb 16; 21():285-91. PubMed ID: 738638
    [No Abstract] [Full Text] [Related]

  • 3. [Possibilities of an immunotherapy of malignant skin tumors with particular consideration of malignant melanomas (author's transl)].
    Schöpf E.
    Ther Umsch; 1976 Aug 16; 33(8):538-42. PubMed ID: 1006610
    [No Abstract] [Full Text] [Related]

  • 4. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
    Peter HH, Deutschmann EM, Schultheis W, Deicher H.
    Dev Biol Stand; 1976 Aug 16; 38():537-40. PubMed ID: 344106
    [Abstract] [Full Text] [Related]

  • 5. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)].
    Wätzig V, Knopf B.
    Arch Geschwulstforsch; 1979 Aug 16; 49(2):140-5. PubMed ID: 475550
    [Abstract] [Full Text] [Related]

  • 6. Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection.
    Moff SL, Corey GR, Gottfredsson M.
    Clin Infect Dis; 1999 Dec 16; 29(6):1569-70. PubMed ID: 10585816
    [No Abstract] [Full Text] [Related]

  • 7. Results of adjuvant BCG immunotherapy in malignant melanoma.
    Wätzig V, Knopf B.
    Arch Geschwulstforsch; 1981 Dec 16; 51(6):493-6. PubMed ID: 7332442
    [Abstract] [Full Text] [Related]

  • 8. [Immunotherapy of melanoma (proceedings)].
    Bolund C.
    Lakartidningen; 1978 Dec 06; 75(49):4598. PubMed ID: 723350
    [No Abstract] [Full Text] [Related]

  • 9. Primary inoculation tuberculosis after immunotherapy for malignant melanoma with BCG vaccine.
    Caplan SE, Kauffman CL.
    J Am Acad Dermatol; 1996 Nov 06; 35(5 Pt 1):783-5. PubMed ID: 8912582
    [No Abstract] [Full Text] [Related]

  • 10. Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma.
    Dandapat MC, Mohapatra SK, Patra SK.
    Indian J Cancer; 1985 Jun 06; 22(2):100-7. PubMed ID: 3842124
    [No Abstract] [Full Text] [Related]

  • 11. [Cancer immunotherapy in dermatological view (author's transl)].
    Lübbe D, Gstöttner R.
    Arch Geschwulstforsch; 1980 Jun 06; 50(2):182-5. PubMed ID: 7436703
    [Abstract] [Full Text] [Related]

  • 12. [Immunotherapy of malignant melanoma].
    Adler A.
    Harefuah; 1986 Jul 06; 111(1-2):11-7. PubMed ID: 3781371
    [No Abstract] [Full Text] [Related]

  • 13. [Combined immunotherapy and cytostatic therapy in stage II and III malignant melanoma (proceedings)].
    Rundenstam CM.
    Lakartidningen; 1978 Dec 06; 75(49):4568-9. PubMed ID: 723339
    [No Abstract] [Full Text] [Related]

  • 14. [Intralesion BCG vaccine therapy in cutaneous melanoma metastasis].
    Wolf M, Menzel W.
    Dermatol Monatsschr; 1978 Sep 06; 164(9):671-2. PubMed ID: 710658
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of malignant melanoma by intratumoral injection of BCG.
    Pinsky CM, Hirshaut Y, Oettgen HF.
    Natl Cancer Inst Monogr; 1973 Dec 06; 39():225-8. PubMed ID: 4595322
    [No Abstract] [Full Text] [Related]

  • 16. [Problems of the immunotherapy of malignant neoplasma].
    Trapeznikov NN, Iavorskiĭ VV.
    Klin Med (Mosk); 1975 May 06; 52(5):15-22. PubMed ID: 1094178
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms].
    Grigorovich NA, Risina DIa, Nodel'son SE.
    Vopr Onkol; 1984 May 06; 30(7):102-6. PubMed ID: 6464396
    [Abstract] [Full Text] [Related]

  • 18. [Current aspects of melanoma research. II. Immunotherapy].
    Wätzig V.
    Dermatol Monatsschr; 1977 May 06; 163(5):359-66. PubMed ID: 881082
    [No Abstract] [Full Text] [Related]

  • 19. Cromolyn prevents bronchospastic attacks caused by Bacillus Calmette Geurin immunotherapy for malignant melanoma patient.
    Wishnitzer R, Eliraz A, Fink A.
    Ann Allergy; 1985 Aug 06; 55(2):167-9. PubMed ID: 3927789
    [Abstract] [Full Text] [Related]

  • 20. Immunotherapy of patients with cancer.
    Smith GV, Morse PA, Deraps GD, Raju S, Hardy JD.
    Surgery; 1973 Jul 06; 74(1):59-68. PubMed ID: 4715883
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.